TTR and Parkinson disease: Amyloidosis, including neurodegenerative diseases such as Alzheimer’s disease or Parkinson’s disease as well as systemic diseases such as reactive systemic amyloidosis, TTR, and light chain amyloidosis are increasingly recognized as important death factors for public health systems.